Imunon
(NASDAQ) CLSN
Imunon Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$250.00K
Net Income (TTM)
$28.87B
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CLSN News
3 Biotech Stocks To Avoid
A Fool Looks Back
The Fool Looks Ahead
This Week in Biotech
Why Celsion Shares Were Eviscerated
CLSN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Imunon
Industry
Biotechnology
Sector
Health CareEmployees
25
CEO
Stacy R. Lindborg, PhD
Website
imunon.comHeadquarters
Lawrence Township, NJ 08648, US
CLSN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-5%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$19.13B
EBITDA
$19.13B
Operating Cash Flow
$18.85B
Capital Expenditure
$29.54M
Free Cash Flow
$18.88B
Cash & ST Invst.
$0.00
Total Debt
$1.14B
Imunon Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
29
N/A
Net Income
$3.43B
+29.2%
EBITDA
$3.43B
+30.9%
Quarterly Fundamentals
Net Cash
$1.10B
+12.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$708.10M
-6.5%
Short Term Debt
$394.13M
-22.5%
Return on Assets
-1.59%
N/A
Return on Invested Capital
-3.03%
N/A
Free Cash Flow
$1.34B
+90.7%
Operating Cash Flow
$1.60B
+88.9%